文献速递脑血管病

高脂血症多基因易感性与缺血性卒中幸存者胆固醇控制及卒中复发相关

Association of Polygenic Susceptibility to Hyperlipidemia With Cholesterol Control and Recurrent Stroke in Ischemic Stroke Survivors.
PubMed 文献 · Neurology · 2025-08-18

基于VISP试验1,567例缺血性卒中幸存者的遗传关联研究显示,高脂血症多基因易感性(PSH)高者血脂未控制风险升高66%、卒中复发风险翻倍、急性冠脉事件风险升高87%,并在UK Biobank 1,634例幸存者中重复了血脂控制关联。

要点

  • 高PSH与血脂未控制、抵抗及卒中复发风险升高相关。
  • PSH高者LDL-c未控制风险OR 1.66,卒中复发HR 2.12。
  • 结果在UK Biobank卒中幸存者中重复验证。

核心结论

  • 在急性缺血性卒中幸存者中,较高的高脂血症多基因易感性与更差的血脂控制和更高的复发性血管事件风险相关。

研究设计与样本

  • 遗传关联研究,使用VISP临床试验中1,567例缺血性卒中幸存者数据,平均年龄68岁,女性35%。
  • PSH基于38个独立LDL-c遗传风险变异构建多基因风险评分,按百分位分为低(<20)、中(20-80)、高(>80)三组。
  • 在UK Biobank的1,634例缺血性卒中幸存者(平均年龄61岁,女性32%)中重复验证。

主要发现

  • 高PSH vs 低PSH:血脂未控制(LDL-c >100 mg/dL)风险OR 1.66(95%CI 1.17-2.35)。
  • 抵抗性高脂血症(LDL-c >100 mg/dL despite statin treatment)风险OR 1.80(95%CI 0.99-3.29)。
  • 卒中复发风险HR 2.12(95%CI 1.19-3.78),急性冠脉事件风险HR 1.87(95%CI 1.21-2.87)。
  • UK Biobank重复验证:血脂未控制OR 2.34(95%CI 1.67-3.27),抵抗性高脂血症OR 2.33(95%CI 1.61-3.37)。

临床怎么用

  • 对缺血性卒中幸存者,可考虑评估高脂血症多基因易感性以识别血脂控制失败高风险者。
  • 高PSH者可能需要更积极的血脂监测和管理,以降低复发血管事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Common genetic variation significantly influences the risk of stroke, and previous research has indicated that polygenic susceptibility to hypertension and diabetes negatively affects the clinical trajectory of ischemic stroke survivors. We hypothesize that polygenic susceptibility to hyperlipidemia (PSH) negatively affects cholesterol control in this same population. METHODS: We conducted a genetic association study using data from the Vitamin Intervention Stroke Prevention (VISP) study, a clinical trial that enrolled survivors of ischemic stroke. PSH was modeled using a polygenic risk score built with 38 independent genetic risk variants for low-density lipoprotein cholesterol (LDL-c), which was divided into <20, 20-80, and >80 percentile categories labeled as low, intermediate, and high PSH, respectively. We used multivariable linear, logistic, and Cox regression, as appropriate, to test whether high PSH was associated with risk of uncontrolled hyperlipidemia (HLD) (LDL-c >100 mg/dL), resistant HLD (LDL-c >100 mg/dL despite statin treatment), and clinical outcomes. We replicated our findings in a cohort of ischemic stroke survivors enrolled in the UK Biobank. RESULTS: A total of 1,567 ischemic stroke survivors (mean age 68 years, 35% female) enrolled in VISP were included in the study. Stroke survivors with higher vs low PSH had 66% higher risk of uncontrolled HLD (OR 1.66, 95% CI 1.17-2.35), 80% higher risk of resistant HLD (1.80, 95% CI 0.99-3.29), twice the risk of recurrent stroke (hazard ratio [HR] 2.12, 95% CI 1.19-3.78), and 87% higher risk of acute coronary events (HR 1.87, 95% CI 1.21-2.87). The association between high PSH and higher risk of uncontrolled and resistant HLD was replicated in 1,634 stroke survivors (mean age 61, 32% female) enrolled in the UK Biobank (OR 2.34, 95% CI 1.67-3.27, and OR 2.33, 95% CI 1.61-3.37, respectively). DISCUSSION: Among acute ischemic stroke survivors, higher PSH is associated with worse lipid control and higher risk of recurrent vascular events. Our findings, combined with existing evidence on the role of adverse genetic profiles in blood pressure and glycemic control in this population, support the comprehensive evaluation of polygenic profiles as a cause of failed risk factor control in stroke survivors and its role in developing precision medicine tools for post-stroke clinical management.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wu K, Huo S, Rivier CA, et al. Association of Polygenic Susceptibility to Hyperlipidemia With Cholesterol Control and Recurrent Stroke in Ischemic Stroke Survivors. Neurology. 2025. PMID: 40825160. doi:10.1212/WNL.0000000000213966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。